Graft-versus-host disease (GVHD) is a serious complication that can occur after stem cell transplantation, where the donor’s immune cells mistakenly...
Vous n'êtes pas connecté
Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the donor's immune cells attack the recipient's tissues.
Graft-versus-host disease (GVHD) is a serious complication that can occur after stem cell transplantation, where the donor’s immune cells mistakenly...
New research highlights the promise of a novel stem cell treatment strategy for leptomeningeal brain metastasis (LBM), a severe form of metastatic...
Fresh from FDA approval for its stem-cell product for paediatric graft-versus-host disease, Mesoblast is pursuing consent for indications of heart ...
Scientists have discovered stem-like T cells, offering new hope for fighting cancer and chronic illnesses by boosting immune response and treatment...
CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a patient's own immune T cells...
Engineered immune cells called CAR-T cells are used in the treatment of cancer. Researchers from Uppsala University have now discovered that CAR...
Cancer is a disease that affects millions of people around the world, and treating it often involves tough decisions. One of the most common...
Innovative muscle patches derived from stem cells demonstrate efficacy in heart repair, improving function in primates and a human patient, with...
Clinical trials find one-time gene therapy exa-cel offers ‘functional cure’ in 96.6% of patients